Patent application number | Description | Published |
20090112559 | MODEL-DRIVEN, REPOSITORY-BASED APPLICATION MONITORING SYSTEM - Enabling and processing events. To enable events, an application model correlated to an application is declaratively defined. The application model describes operations of the application. One or more event models correlated to the application model are declaratively defined. The event models describe application execution locations where events are desired to be emitted in the execution of the application. Based on the correlation of the event models to the application models, the applications are instrumented with instrumentation code to cause the application to emit events at the execution locations. To process events an application model is defined. The application model includes one or more observation models. The observation models include a correlation of events to the observation model by defining instrumentation models in the application model. An event is received. The event is applied to the observation model based on the correlation. The event is processed according to the observation model. | 04-30-2009 |
20090113437 | TRANSLATING DECLARATIVE MODELS - The present invention extends to methods, systems, and computer program products for translating declarative models. Embodiments of the present invention facilitate processing declarative models to perform various operations on applications, such as, for example, application deployment, application updates, application control such as start and stop, application monitoring by instrumenting the applications to emit events, and so on. Declarative models of applications are processed and realized onto a target environment, after which they can be executed, controlled, and monitored. | 04-30-2009 |
20120042305 | TRANSLATING DECLARATIVE MODELS - The present invention extends to methods, systems, and computer program products for translating declarative models. Embodiments of the present invention facilitate processing declarative models to perform various operations on applications, such as, for example, application deployment, application updates, application control such as start and stop, application monitoring by instrumenting the applications to emit events, and so on. Declarative models of applications are processed and realized onto a target environment, after which they can be executed, controlled, and monitored. | 02-16-2012 |
Patent application number | Description | Published |
20080269108 | Crystalline forms of the Di-Sodium Salt of N-(5-Chlorosalicyloyl)-8-Aminocaprylic Acid - The present invention relates to crystalline polymorphic forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid, pharmaceutical compositions containing the same, methods of preparing the same, and methods for facilitating the delivery of active agents with the same. | 10-30-2008 |
20100055194 | PHARMACEUTICAL FORMULATIONS CONTAINING MICROPARTICLES OR NANOPARTICLES OF A DELIVERY AGENT - This invention relates to microparticles and/or nanoparticles containing a delivery agent and/or an active agent. This invention also relates to pharmaceutical formulations and solid dosage forms, including controlled release solid dosage forms of active agent and a delivery agent. | 03-04-2010 |
20120065128 | CRYSTALLINE FORMS OF THE DI-SODIUM SALT OF N-(5-CHLOROSALICYLOYL)-8-AMINOCAPRYLIC ACID - The present invention relates to crystalline polymorphic forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid, pharmaceutical compositions containing the same, methods of preparing the same, and methods for facilitating the delivery of active agents with the same. | 03-15-2012 |
20120189666 | PHARMACEUTICAL FORMULATIONS CONTAINING MICROPARTICLES OR NANOPARTICLES OF A DELIVERY AGENT - This invention relates to microparticles and/or nanoparticles containing a delivery agent and/or an active agent. This invention also relates to pharmaceutical formulations and solid dosage forms, including controlled release solid dosage forms of active agent and a delivery agent. | 07-26-2012 |
20130281471 | Acyclovir Formulations - The present invention relates to an acyclovir formulation having improved bioavailability resulting in better efficacy and/or requiring less frequent administration. | 10-24-2013 |
20130303444 | CRYSTALLINE FORMS OF THE DI-SODIUM SALT OF N-(5-CHLOROSALICYLOYL)-8-AMINOCAPRYLIC ACID - The present invention relates to crystalline polymorphic forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid, pharmaceutical compositions containing the same, methods of preparing the same, and methods for facilitating the delivery of active agents with the same. | 11-14-2013 |